Impact of Extracellular pH on Apoptotic and Non-Apoptotic TRAIL-Induced Signaling in Pancreatic Ductal Adenocarcinoma Cells

por Hagelund, Sofie, Trauzold, Anna
Publicado 2022

Downregulation of TRAIL-Receptor 1 Increases TGFβ Type II Receptor Expression and TGFβ Signalling Via MicroRNA-370-3p in Pancreatic Cancer Cells

por Radke, David I., Ling, Qi, Häsler, Robert, Alp, Gökhan, Ungefroren, Hendrik, Trauzold, Anna
Publicado 2018

Impact of p53 status on TRAIL-mediated apoptotic and non-apoptotic signaling in cancer cells

por Willms, Anna, Schittek, Hella, Rahn, Sascha, Sosna, Justyna, Mert, Ufuk, Adam, Dieter, Trauzold, Anna
Publicado 2019

Synergistic effects of agonists and two-pore-domain potassium channels on secretory responses of human pancreatic duct cells Capan-1

por Sørensen, Christiane E., Trauzold, Anna, Christensen, Nynne M., Tawfik, Doaa, Szczepanowski, Monika, Novak, Ivana
Publicado 2022

Combination phenylbutyrate/gemcitabine therapy effectively inhibits in vitro and in vivo growth of NSCLC by intrinsic apoptotic pathways

por Schniewind, Bodo, Heintz, Kirsten, Kurdow, Roland, Ammerpohl, Ole, Trauzold, Anna, Emme, Doris, Dohrmann, Peter, Kalthoff, Holger
Publicado 2006

Assessment of anti-inflammatory tumor treatment efficacy by longitudinal monitoring employing sonographic micro morphology in a preclinical mouse model

por Tiwari, Sanjay, Egberts, Jan H, Korniienko, Olena, Köhler, Linda, Trauzold, Anna, Glüer, Claus C, Kalthoff, Holger
Publicado 2011

The A818–6 system as an in-vitro model for studying the role of the transportome in pancreatic cancer

por Tawfik, Doaa, Zaccagnino, Angela, Bernt, Alexander, Szczepanowski, Monika, Klapper, Wolfram, Schwab, Albrecht, Kalthoff, Holger, Trauzold, Anna
Publicado 2020

Should We Keep Walking along the Trail for Pancreatic Cancer Treatment? Revisiting TNF-Related Apoptosis-Inducing Ligand for Anticancer Therapy

por Kretz, Anna-Laura, von Karstedt, Silvia, Hillenbrand, Andreas, Henne-Bruns, Doris, Knippschild, Uwe, Trauzold, Anna, Lemke, Johannes
Publicado 2018

TRAILblazing Strategies for Cancer Treatment

por Kretz, Anna-Laura, Trauzold, Anna, Hillenbrand, Andreas, Knippschild, Uwe, Henne-Bruns, Doris, von Karstedt, Silvia, Lemke, Johannes
Publicado 2019

Endogenous TRAIL-R4 critically impacts apoptotic and non-apoptotic TRAIL-induced signaling in cancer cells

por Rambow, Anna-Christina, Aschenbach, Insa, Hagelund, Sofie, Tawfik, Doaa, Gundlach, Jan-Paul, Weiße, Sebastian, Maass, Nicolai, Trauzold, Anna
Publicado 2022

TRAIL-Receptor 4 Modulates γδ T Cell-Cytotoxicity Toward Cancer Cells

por Tawfik, Doaa, Groth, Christopher, Gundlach, Jan-Paul, Peipp, Matthias, Kabelitz, Dieter, Becker, Thomas, Oberg, Hans-Heinrich, Trauzold, Anna, Wesch, Daniela
Publicado 2019

TRAIL-induced programmed necrosis as a novel approach to eliminate tumor cells

por Voigt, Susann, Philipp, Stephan, Davarnia, Parvin, Winoto-Morbach, Supandi, Röder, Christian, Arenz, Christoph, Trauzold, Anna, Kabelitz, Dieter, Schütze, Stefan, Kalthoff, Holger, Adam, Dieter
Publicado 2014

Identifying patients with an unfavorable prognosis in early stages of colorectal carcinoma

por Hendricks, Alexander, Eggebrecht, Greta-Lou, Bernsmeier, Alexander, Geisen, Reinhild, Dall, Katharina, Trauzold, Anna, Becker, Thomas, Kalthoff, Holger, Schafmayer, Clemens, Röder, Christian, Hinz, Sebastian
Publicado 2018

Cytoplasmic TRAIL-R1 is a positive prognostic marker in PDAC

por Gundlach, Jan-Paul, Hauser, Charlotte, Schlegel, Franka Maria, Böger, Christine, Röder, Christian, Röcken, Christoph, Becker, Thomas, Egberts, Jan-Hendrik, Kalthoff, Holger, Trauzold, Anna
Publicado 2018

TRAIL Induces Nuclear Translocation and Chromatin Localization of TRAIL Death Receptors

por Mert, Ufuk, Adawy, Alshaimaa, Scharff, Elisabeth, Teichmann, Pierre, Willms, Anna, Haselmann, Verena, Colmorgen, Cynthia, Lemke, Johannes, von Karstedt, Silvia, Fritsch, Jürgen, Trauzold, Anna
Publicado 2019

The prognostic relevance of primary tumor location in patients undergoing resection for pancreatic ductal adenocarcinoma

por Ling, Qi, Xu, Xiao, Ye, Panpan, Xie, Haiyang, Gao, Feng, Hu, Qichao, Liu, Zhikun, Wei, Xuyong, Röder, Christian, Trauzold, Anna, Kalthoff, Holger, Zheng, Shusen
Publicado 2017

Prognostic significance of high mobility group A2 (HMGA2) in pancreatic ductal adenocarcinoma: malignant functions of cytoplasmic HMGA2 expression

por Gundlach, Jan-Paul, Hauser, Charlotte, Schlegel, Franka Maria, Willms, Anna, Halske, Christine, Röder, Christian, Krüger, Sandra, Röcken, Christoph, Becker, Thomas, Kalthoff, Holger, Trauzold, Anna
Publicado 2021

Tumor-reducing effect of the clinically used drug clofazimine in a SCID mouse model of pancreatic ductal adenocarcinoma

por Zaccagnino, Angela, Managò, Antonella, Leanza, Luigi, Gontarewitz, Artur, Linder, Bernhard, Azzolini, Michele, Biasutto, Lucia, Zoratti, Mario, Peruzzo, Roberta, Legler, Karen, Trauzold, Anna, Kalthoff, Holger, Szabo, Ildiko
Publicado 2016

The Hepatic Microenvironment and TRAIL-R2 Impact Outgrowth of Liver Metastases in Pancreatic Cancer after Surgical Resection

por Miarka, Lauritz, Hauser, Charlotte, Helm, Ole, Holdhof, Dörthe, Beckinger, Silje, Egberts, Jan-Hendrik, Gundlach, Jan-Paul, Lenk, Lennart, Rahn, Sascha, Mikulits, Wolfgang, Trauzold, Anna, Sebens, Susanne
Publicado 2019

TRAIL-receptor 2—a novel negative regulator of p53

por Willms, Anna, Schupp, Hella, Poelker, Michelle, Adawy, Alshaimaa, Debus, Jan Frederik, Hartwig, Torsten, Krichel, Tim, Fritsch, Jürgen, Singh, Steven, Walczak, Henning, von Karstedt, Silvia, Schäfer, Heiner, Trauzold, Anna
Publicado 2021